National Health (Highly Specialised Drugs Program) Special Arrangement 2021
5Simplified outline of this instrument
Start here
Get a plain-English read of 5
Turn the raw legal text into a practical explanation grounded in National Health (Highly Specialised Drugs Program) Special Arrangement 2021.
5 Simplified outline of this instrument
This instrument makes a special arrangement for the supply of pharmaceutical benefits that contain highly specialised drugs for the treatment of chronic conditions.
Restrictions apply to the prescribing and supply of these benefits because of their clinical use and other special features.
The prescribing of these benefits is in most cases limited to practitioners who have undertaken particular training or are affiliated with a specialised hospital unit.
The supply of these benefits is restricted to persons who are receiving treatment by medical practitioners and authorised nurse practitioners.
These benefits will be supplied by approved suppliers (public and private hospitals, community pharmacies and certain medical practitioners).
This instrument also deals with payments for supplies of these pharmaceutical benefits.
Note: Part VII of the Act, and regulations or other instruments made for the purposes of that Part, have effect subject to this instrument (see subsection 100(3) of the Act).